{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T03:17:08Z","timestamp":1789096628269,"version":"build-2803163510"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2010,5,25]],"date-time":"2010-05-25T00:00:00Z","timestamp":1274745600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1007\/s12032-010-9570-8","type":"journal-article","created":{"date-parts":[[2010,5,24]],"date-time":"2010-05-24T16:43:38Z","timestamp":1274719418000},"page":"1555-1558","source":"Crossref","is-referenced-by-count":9,"title":["Concomitant presence of JAK2 V617F mutation and BCR-ABL translocation in a pregnant woman with polycythemia vera"],"prefix":"10.1007","volume":"28","author":[{"given":"Gholamreza","family":"Toogeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirin","family":"Ferdowsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Naadali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamran","family":"Alimoghaddam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ardeshir","family":"Ghavamzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Shirkoohi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed H.","family":"Ghaffari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,5,25]]},"reference":[{"key":"9570_CR1","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(05)74230-6","volume":"365","author":"EJ Baxter","year":"2005","unstructured":"Baxter EJ, et al. Acquired mutation of thetyrosine kinase JAK2 in human myeloproliferative disorders. Lancet. 2005;365:1054\u201361.","journal-title":"Lancet"},{"key":"9570_CR2","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ccr.2005.03.023","volume":"7","author":"RL Levine","year":"2005","unstructured":"Levine RL, et al. Activating mutation in thetyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. Cancer Cell. 2005;7:387\u201397.","journal-title":"Cancer Cell"},{"key":"9570_CR3","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1056\/NEJMp068293","volume":"356","author":"A Tefferi","year":"2007","unstructured":"Tefferi A. JAK2 mutations in polycythemia vera\u2014molecular mechanisms and clinical applications. New Eng J Med. 2007;356:444\u20135.","journal-title":"New Eng J Med"},{"key":"9570_CR4","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1038\/sj.leu.2405088","volume":"22","author":"N Cambier","year":"2008","unstructured":"Cambier N, et al. JAK2V617F-positive polycythemia vera and Philadelphia chromosome-positive chronic myeloid leukemia: one patient with two distinct myeloproliferative disorders. Leukemia. 2008;22:1454\u20135.","journal-title":"Leukemia"},{"key":"9570_CR5","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.5858\/2007-131-1719-TOPVTC","volume":"131","author":"I Mirza","year":"2007","unstructured":"Mirza I, Frantz C, Clarke G, Voth A, Turner R. Transformation of polycythemia vera to chronic myelogenous leukemia. Arch Pathol Lab Med. 2007;131:1719\u201324.","journal-title":"Arch Pathol Lab Med"},{"key":"9570_CR6","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s12185-009-0471-6","volume":"91","author":"CB Ping","year":"2010","unstructured":"Ping CB, Gan GG, Nadarajan VS, Latiff NA, Menaka N. A man with concomitant polycythaemia vera and chronic myeloid leukemia: the dynamics of the two disorders. Int J Hematol. 2010;91:136\u20139.","journal-title":"Int J Hematol"},{"key":"9570_CR7","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3816\/CLM.2009.n.080","volume":"9","author":"S Pingali","year":"2009","unstructured":"Pingali S, Mathiason M, Lovrich S, Ronald S. Emergence of chronic myelogenous leukemia from a background of myeloproliferative disorder: JAK2V617F as a potential risk factor for BCR-ABL translocation. Clin Lymphoma Myeloma. 2009;9:25\u20139.","journal-title":"Clin Lymphoma Myeloma"},{"key":"9570_CR8","first-page":"657","volume":"30","author":"AL Centrone","year":"1967","unstructured":"Centrone AL, Freda RN, McGowan L. Polycythemia rubra vera in pregnancy. Obstet Gynecol. 1967;30:657\u20139.","journal-title":"Obstet Gynecol"},{"key":"9570_CR9","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1001\/archinte.120.6.697","volume":"120","author":"RE Harris","year":"1967","unstructured":"Harris RE, Conrad FG. Polycythemia vera in the childbearing age. Arch Intern Med. 1967;120:697\u2013700.","journal-title":"Arch Intern Med"},{"key":"9570_CR10","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1055\/s-2004-823773","volume":"21","author":"O Pata","year":"2004","unstructured":"Pata O, et al. Polycythemia vera and pregnancy: a case report with the use of hydroxyurea in the first trimester. Am J Perinatol. 2004;21:135\u20137.","journal-title":"Am J Perinatol"},{"key":"9570_CR11","first-page":"230","volume":"18","author":"A Hochman","year":"1961","unstructured":"Hochman A, Stein JA. Polycythemia and pregnancy. Report of a case. Obstet Gynecol. 1961;18:230\u20135.","journal-title":"Obstet Gynecol"},{"key":"9570_CR12","first-page":"16s","volume":"62","author":"JE Ferguson 2nd","year":"1983","unstructured":"Ferguson JE 2nd, Ueland K, Aronson WJ. Polycythemia rubra vera and pregnancy. Obstet Gynecol. 1983;62:16s\u201320s.","journal-title":"Obstet Gynecol"},{"key":"9570_CR13","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1182\/blood-2005-03-1320","volume":"106","author":"AV Jones","year":"2005","unstructured":"Jones AV, et al. Widespread occurrence of the JAK2V617F mutation in chronic myeloproliferative disorders. Blood. 2005;106:2162\u20138.","journal-title":"Blood"},{"key":"9570_CR14","first-page":"247","volume":"11","author":"M Yaghmaie","year":"2008","unstructured":"Yaghmaie M, et al. Frequency of BCR-ABL fusion transcripts in Iranian patients with chronic myeloid leukemia. Arch Iran Med. 2008;11:247\u201351.","journal-title":"Arch Iran Med"},{"key":"9570_CR15","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0002-9343(00)00449-6","volume":"109","author":"A Tefferi","year":"2000","unstructured":"Tefferi A, Solberg LA, Silverstein MN. A clinical up date in polycythemia vera and essential thrombocythemia. Am J Med. 2000;109:141\u20139.","journal-title":"Am J Med"},{"key":"9570_CR16","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/sj.leu.2404069","volume":"20","author":"C James","year":"2006","unstructured":"James C, et al. Detection of JAK2 V617F as a first intention diagnostic test for erythrocytosis. Leukemia. 2006;20:350\u20133.","journal-title":"Leukemia"},{"key":"9570_CR17","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1600-0609.2005.00488.x","volume":"75","author":"A Saviola","year":"2005","unstructured":"Saviola A, et al. Transition of polycythemia vera to chronic myeloid leukaemia. Eur J Haematol. 2005;75:264\u20136.","journal-title":"Eur J Haematol"},{"key":"9570_CR18","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/ajh.2830370318","volume":"37","author":"E Jantunen","year":"1991","unstructured":"Jantunen E, Nousiainen T. Ph-positive chronic myelogenous leukemia evolving after polycythemiavera. Am J Hematol. 1991;37:212.","journal-title":"Am J Hematol"},{"key":"9570_CR19","doi-asserted-by":"crossref","first-page":"820","DOI":"10.7326\/0003-4819-83-6-820","volume":"83","author":"EC Hoppin","year":"1975","unstructured":"Hoppin EC, Lewis JP. Polycythemia rubra vera progressing to Ph-positive chronic myelogenous leukemia. Ann Intern Med. 1975;83:820\u20133.","journal-title":"Ann Intern Med"},{"key":"9570_CR20","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/ajh.2830350209","volume":"35","author":"AU Haq","year":"1990","unstructured":"Haq AU. Transformation of polycythemia vera to Ph-positive chronic myelogenous leukemia. Am J Hematol. 1990;35:110\u20133.","journal-title":"Am J Hematol"},{"key":"9570_CR21","first-page":"357","volume":"19","author":"E Mercier","year":"2007","unstructured":"Mercier E, Lissalde-Lavigne G, Gris J. JAK2 V617F mutation in unexplained loss of first pregnancy. N Engl J Med. 2007;19:357.","journal-title":"N Engl J Med"},{"key":"9570_CR22","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1182\/blood-2008-01-134114","volume":"112","author":"I Plo","year":"2008","unstructured":"Plo I, et al. JAK2 stimulates homologous recombination and genetic instability: potential implication in the heterogeneity of myeloproliferative disorders. Blood. 2008;112:1402\u201312.","journal-title":"Blood"},{"key":"9570_CR23","doi-asserted-by":"crossref","first-page":"6188","DOI":"10.1038\/sj.onc.1204834","volume":"20","author":"S Xie","year":"2001","unstructured":"Xie S, et al. Involvement of Jak2 tyrosine phosphorylation in bcrabl transformation. Oncogene. 2001;20:6188\u201395.","journal-title":"Oncogene"},{"key":"9570_CR24","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1365-2141.1988.tb02427.x","volume":"70","author":"CM Morris","year":"1998","unstructured":"Morris CM, et al. Essential thrombocythemia and the Philadelphia chromosome. Br J Haematol. 1998;70:13\u20137.","journal-title":"Br J Haematol"},{"key":"9570_CR25","first-page":"563","volume":"3","author":"P Martiat","year":"1989","unstructured":"Martiat P, et al. Molecular analysis of Philadelphia positive essential thrombocythemia. Leukemia. 1989;3:563\u20138.","journal-title":"Leukemia"},{"key":"9570_CR26","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/ajh.2830300111","volume":"30","author":"R Sarode","year":"1989","unstructured":"Sarode R, Marwaha N, Gupta RK, Garewal G. Philadelphia chromosome in essential thrombocythaemia? (letter). Am J Hematol. 1989;30:45.","journal-title":"Am J Hematol"},{"key":"9570_CR27","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/ajh.2830270202","volume":"27","author":"DB Stoll","year":"1998","unstructured":"Stoll DB, et al. Clinical presentation and natural history of patients with essential thrombocythemia and the Philadelphia chromosome. Am J Hematol. 1998;27:77\u201383.","journal-title":"Am J Hematol"},{"key":"9570_CR28","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1182\/blood.V90.7.2768","volume":"90","author":"D Blickstein","year":"1997","unstructured":"Blickstein D, et al. BCR-ABL transcripts in bone marrow aspirates of Philadelphia-negative essential thrombocythemia patients: clinical presentation. Blood. 1997;90:2768\u201371.","journal-title":"Blood"},{"key":"9570_CR29","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.lab.2003.10.007","volume":"143","author":"HC Hsu","year":"2004","unstructured":"Hsu HC. Detrction of bcr-abl gene expression at a low level in blood cells of some patients with essential thrombocythemia. J Lab Clin Med. 2004;143:125\u20139.","journal-title":"J Lab Clin Med"},{"key":"9570_CR30","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/0165-4608(94)00108-1","volume":"89","author":"YL Kwong","year":"1996","unstructured":"Kwong YL, Chiu EK, Liang RH, Chan V, Chan TK. Essential thrombocythemia with BCR\/ABL rearrangement. Cancer Genet Cytogenet. 1996;89:74\u20136.","journal-title":"Cancer Genet Cytogenet"},{"key":"9570_CR31","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3109\/10428199909093727","volume":"33","author":"A Aviram","year":"1999","unstructured":"Aviram A, et al. Significance of BCR-ABL transcripts in bone marrow aspirates of Philadelphia-negative essential thrombocythemia patients. Leuk Lymphoma. 1999;33:77\u201382.","journal-title":"Leuk Lymphoma."},{"key":"9570_CR32","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/j.1365-2141.2005.05396.x","volume":"128","author":"NJ Curtin","year":"2005","unstructured":"Curtin NJ, Campbell PJ, Green AR. The Philadelphia translocation and pre-existing myeloproliferative disorders. Br J Haematol. 2005;128:734\u20136.","journal-title":"Br J Haematol"},{"key":"9570_CR33","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1038\/sj.leu.2404730","volume":"21","author":"M Bornha\u00fcser","year":"2007","unstructured":"Bornha\u00fcser M, et al. Concurrent JAK2 (V617F) mutation and BCR-ABL translocation within committed myeloid progenitors in myelofibrosis. Leukemia. 2007;21:1824\u20136.","journal-title":"Leukemia"},{"key":"9570_CR34","doi-asserted-by":"crossref","first-page":"4106","DOI":"10.1182\/blood-2006-12-061135","volume":"109","author":"K Hussein","year":"2007","unstructured":"Hussein K, et al. Myelofibrosis evolving during imatinib treatment of a chronic myeloproliferative disease with coexisting BCR-ABL translocation and JAK2V617F mutation. Blood. 2007;109:4106\u20137.","journal-title":"Blood"},{"key":"9570_CR35","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1055\/s-2006-942763","volume":"32","author":"M Griesshammer","year":"2006","unstructured":"Griesshammer M, Struve S, Harrison CM. Essential thrombocythemia\/polycythemia vera and pregnancy: the need for an observational study in Europe. Semin Thromb Hemost. 2006;32:422\u20139.","journal-title":"Semin Thromb Hemost"},{"key":"9570_CR36","first-page":"1477","volume":"90","author":"S Robinson","year":"2005","unstructured":"Robinson S, Bewley S, Hunt B, Radia D, Harrison C. The management and outcome of 18 pregnancies in women with polycythemia vera. Haematologica. 2005;90:1477\u201383.","journal-title":"Haematologica"},{"key":"9570_CR37","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1182\/blood-2007-01-071068","volume":"110","author":"F Passamonti","year":"2007","unstructured":"Passamonti F, et al. Increased risk of pregnancy complications in patients with essential thrombocythemia carrying the JAK2 (617V_F) mutation. Blood. 2007;110:485\u20139.","journal-title":"Blood"},{"key":"9570_CR38","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1034\/j.1600-0609.2001.00367.x","volume":"66","author":"CA Wright","year":"2001","unstructured":"Wright CA, Tefferi A. A single institutional experience with 43 pregnancies in essential thrombocythemia. Eur J Haematol. 2001;66:152\u20139.","journal-title":"Eur J Haematol"},{"key":"9570_CR39","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1034\/j.1600-0609.2000.90214.x","volume":"65","author":"M Bangerter","year":"2000","unstructured":"Bangerter M, et al. Pregnancy in essential thrombocythaemia: treatment and outcome of 17 pregnancies. Eur J Haematol. 2000;65:165\u20139.","journal-title":"Eur J Haematol"},{"key":"9570_CR40","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1034\/j.1600-0412.2000.079009803.x","volume":"79","author":"M Celiloglu","year":"2000","unstructured":"Celiloglu M, Altnyurt S, Undar B. Hydroxyurea treatment for chronic myeloid leukemia during pregnancy. Acta Obstet Gyne Scand. 2000;79:803\u20134.","journal-title":"Acta Obstet Gyne Scand"},{"key":"9570_CR41","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1038\/sj.leu.2402494","volume":"16","author":"SA Fadilah","year":"2002","unstructured":"Fadilah SA, Ahmad-Zailani H, Soon-Keng C, Norlaila M. Successful treatment of chronic myeloid leukemia during pregnancy with hydroxyurea. Leukemia. 2002;16:1202\u20133.","journal-title":"Leukemia"},{"key":"9570_CR42","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1038\/sj.leu.2402168","volume":"15","author":"C Thauvin-Robinet","year":"2001","unstructured":"Thauvin-Robinet C, et al. Exposure to hydroxyurea during pregnancy: a case series. Leukemia. 2001;15:1309\u201311.","journal-title":"Leukemia"},{"key":"9570_CR43","first-page":"89","volume":"21","author":"C Baykal","year":"2000","unstructured":"Baykal C, Zengin N, Coskun F, Guler N, Ayhan A. Use of hydroxyurea and alpha-interferon in chronic myeloid leukemia during pregnancy: a case report. Eur J Gynaecol Oncol. 2000;21:89\u201399.","journal-title":"Eur J Gynaecol Oncol"},{"key":"9570_CR44","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1182\/blood.V83.3.874.874","volume":"83","author":"N Vianelli","year":"1994","unstructured":"Vianelli N, et al. Interferon-a2a treatment in a pregnant woman with essential thrombocythaemia. Blood. 1994;83:874\u20135.","journal-title":"Blood"},{"key":"9570_CR45","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1600-0609.1994.tb01287.x","volume":"52","author":"S Thornley","year":"1994","unstructured":"Thornley S, Manoharan A. Successful treatment of essential thrombocythaemia with alpha interferon during pregnancy. Eur J Haematol. 1994;52:63\u20134.","journal-title":"Eur J Haematol"},{"key":"9570_CR46","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/j.1365-2141.1994.tb05092.x","volume":"88","author":"JM Williams","year":"1994","unstructured":"Williams JM, Schlesinger PE, Gray AG. Successful treatment of essential thrombocythaemia and recurrent abortion with alpha interferon. Br J Haematol. 1994;88:647\u20138.","journal-title":"Br J Haematol"},{"key":"9570_CR47","first-page":"814","volume":"87","author":"R Delage","year":"1996","unstructured":"Delage R, Demers C, Cantin G, Roy J. Treatment of essential thrombocythemia during pregnancy with interferon alpha. Obstet Gynecol. 1996;87:814\u20137.","journal-title":"Obstet Gynecol"},{"key":"9570_CR48","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/(SICI)1520-6661(199603\/04)5:2<74::AID-MFM5>3.0.CO;2-N","volume":"5","author":"V Milano","year":"1996","unstructured":"Milano V, et al. Successful treatment of essential thrombocythemia in a pregnancy with recombinant interferon-alpha 2a. J Matern Fetal Med. 1996;5:74\u20138.","journal-title":"J Matern Fetal Med"},{"key":"9570_CR49","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/ajh.2830430125","volume":"43","author":"S Pardini","year":"1993","unstructured":"Pardini S, et al. Alpha 2b-interferon therapy and pregnancy: report of a case of essential thrombocythaemia. Am J Hematol. 1993;43:78\u20139.","journal-title":"Am J Hematol"},{"key":"9570_CR50","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1182\/blood-2008-03-143537","volume":"112","author":"J Kiladjian","year":"2008","unstructured":"Kiladjian J, et al. Pegylated interferon-alfa-2a induces complete hematologic and molecular responses with low toxicity in polycythemia vera. Blood. 2008;112:3065\u201372.","journal-title":"Blood"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-010-9570-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12032-010-9570-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-010-9570-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T23:20:33Z","timestamp":1711495233000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12032-010-9570-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5,25]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["9570"],"URL":"https:\/\/doi.org\/10.1007\/s12032-010-9570-8","relation":{},"ISSN":["1357-0560","1559-131X"],"issn-type":[{"value":"1357-0560","type":"print"},{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,5,25]]}}}